![Derrell Porter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Derrell Porter
Direktor/Vorstandsmitglied bei
PASSAGE BIO, INC.
Vermögen: 33 280 $ am 31.05.2026
Profil
Derrell D.
Porter was the founder of Cellevolve Bio, Inc., founded in 2020, where the title held was Chief Executive Officer from 2020 to 2023.
Current jobs include Chief Executive Officer & Director at CTRL Therapeutics, Inc.; Independent Director at Acumen Pharmaceuticals, Inc. since 2023; Director at Biosortia Pharmaceuticals, Inc.; Independent Director at Passage Bio, Inc. since 2021; and Director at Portal Innovations LLC.
Former jobs include Director-Corporate Development & Sales Manager at Amgen, Inc.; Sales Manager & Director-Corporate Development at AbbVie, Inc.; Director at Alliance for Regenerative Medicine; Vice President at Gilead Sciences, Inc. from 2013 to 2017; and Senior Vice President & Global Head-Commercial at Atara Biotherapeutics, Inc. from 2017 to 2019.
Education includes undergraduate studies at the University of California, Los Angeles; MBAistration from The Wharton School of the University of Pennsylvania; and a doctorate from Perelman School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.06.2026 | 12’800 ( 0.02% ) | 33 280 $ | 31.05.2026 | |
PASSAGE BIO, INC. -.--% | 19.05.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Derrell Porter
| Unternehmen | Position | Beginn |
|---|---|---|
| PASSAGE BIO, INC. | Direktor/Vorstandsmitglied | 27.05.2021 |
| ACUMEN PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 04.01.2023 |
Biosortia Pharmaceuticals, Inc.
 Biosortia Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development of algal technologies with focus on concentration, dewatering, drying and extraction of biomass | Direktor/Vorstandsmitglied | - |
Portal Innovations LLC
 Portal Innovations LLC Investment ManagersFinance Portal Innovations invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, medtech and bioinformatics. It provides financing for seed and early stage capital requirements. | Direktor/Vorstandsmitglied | - |
CTRL Therapeutics, Inc.
 CTRL Therapeutics, Inc. BiotechnologyHealth Technology Develops liquid biopsy platform that isolates circulating tumor cells from blood | Vorstandsvorsitzender | 01.11.2023 |
Ehemalige bekannte Positionen von Derrell Porter
| Unternehmen | Position | Ende |
|---|---|---|
Cellevolve Bio
 Cellevolve Bio Pharmaceuticals: MajorHealth Technology Develops and commercializes cell therapies | Vorstandsvorsitzender | 01.11.2023 |
| ATARA BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01.10.2019 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.05.2017 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Direktor/Vorstandsmitglied | - |
| ░░░░░░ ░░░░ | ░░░░░░░░ ░ ░░░░░░░░░ | - |
Ausbildung von Derrell Porter
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
30
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Acumen Pharmaceuticals, Inc.
 Acumen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines and diagnostics for Alzheimer's disease | Health Technology |
Biosortia Pharmaceuticals, Inc.
Biosortia Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development of algal technologies with focus on concentration, dewatering, drying and extraction of biomass | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perelman School of Medicine
 Perelman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
CTRL Therapeutics, Inc.
CTRL Therapeutics, Inc. BiotechnologyHealth Technology Develops liquid biopsy platform that isolates circulating tumor cells from blood | Health Technology |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, medtech and bioinformatics. It provides financing for seed and early stage capital requirements. | Finance |
Cellevolve Bio
Cellevolve Bio Pharmaceuticals: MajorHealth Technology Develops and commercializes cell therapies | Health Technology |
